Real-time enrollment status for this retinitis pigmentosa clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:16 AM UTC
| NCT Number | NCT06789445 |
| Recruiting Status | Recruiting |
| Condition | Retinitis Pigmentosa |
| Phase | Clinical Trial |
| Target Enrollment | 54 participants |
| Active Locations | 2 sites in the US |
| Sponsor | BlueRock Therapeutics |
| Last Updated on CT.gov | December 26, 2025 (Dec 26, 2025) |
As of March 2, 2026: Clinical trial NCT06789445 is currently recruiting participants. This clinical trial study for retinitis pigmentosa is actively seeking new participants at 2 locations across the United States. The study is sponsored by BlueRock Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06789445 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06789445 was last updated Dec 26, 2025 (December 26, 2025). HelloStudys verifies this status automatically.